MyFinsight
Home
Blog
About
Contact
Download
Download image
Investment securities,
available-for-sale
$569,246K
Cash and cash
equivalents
$282,212K
Accounts receivable, net
$135,350K
Prepaid expenses
$64,600K
Inventory
$31,574K
Interest and other
receivables
$13,034K
Total current assets
$1,096,016K
Deferred tax assets
$249,624K
Intangible assets, net
$106,171K
Long-term inventory
$80,719K
Operating lease
right-of-use assets
$46,274K
Property and equipment,
net
$14,652K
Restricted cash
$7,846K
Other assets
$3,928K
Total assets
$1,605,230K
Total liabilities and
stockholders equity
$1,605,230K
Total stockholders
equity
$1,248,066K
Total liabilities
$357,164K
Accumulated deficit
-$1,809,749K
Accumulated other
comprehensive (loss) income
-$563K
Additional paid-in capital
$3,058,362K
Total current
liabilities
$305,524K
Operating lease
liabilities
$39,003K
Other long-term
liabilities
$12,637K
Common stock, 0.0001
par value...
$16K
Accrued liabilities
$293,278K
Accounts payable
$12,246K
Accrued sales
allowances
$160,804K
Accrued consulting and
professional fees
$43,448K
Employee-related liabilities,
current, total
$31,429K
Accrued research and
development services
$19,284K
Other
$16,123K
Operating lease,
liability, current
$11,791K
Accrued royalties
$10,399K
Back
Back
Balance Sheet
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)
source: myfinsight.com